Rhabdomyosarcoma with unknown primary tumor site. A report from
European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
M.C. Affinita MD1, J.H.M Merks MD,
PhD2, J. C. Chisholm MD, PhD3, S.
Haouy MD4, A. Rome MD5, M. Rabusin
MD6, B. Brennan MD, PhD7, G. Bisogno
MD, PhD1
1 Pediatric Hematology, Oncology and Stem Cell
Transplant Division. Department of Women’s and Children’s Health
University Hospital of Padova, Padova Italy
2 Princess Máxima Center for Pediatric Oncology,
Utrecht, Netherlands
3 Children and Young People’s Unit, The Royal Marsden
NHS Foundation Trust and Institute of Cancer Research, Sutton, United
Kingdom
4 Department of Pediatric Oncology, Montpellier
University Hospital Centre, Montpellier, France.
5 Department of Pediatric Immunology, Hematology and
Oncology, Children’s Hospital of La Timone, AP-HM, Marseille, France
6 Department of Pediatric, Hemato-Oncology Unit, IRCCS
Burlo Garofolo, Trieste, Ita
7 Pediatric Oncology, Royal Manchester Children’s
Hospital, Manchester, UK.